SAN GABRIEL, California, June 14, 2017 /PRNewswire/ --
ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"),the premier financial information website for Chinese-speaking investors, today announces that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. CBD Biotechnology Inc. will focus on research, development
In April 2017, fulfilling a campaign pledge, Prime Minister Justin Trudeau introduced legislation to legalize the recreational use of marijuana in Canada by the middle of 2018. Canada will become the second country to completely legalize marijuana as a consumer product. The law will require purchasers to be at least 18 years old, and it will limit the amount they can carry at any one time to 30 grams. While the federal government will license and regulate growers, each of Canada's provinces will need to decide exactly how the drug will be distributed and sold within its boundaries.
"I am delighted about the incorporation of CBD Biotechnology Inc.," says Warren Wang, founder and CEO of CIIX. "CBD Biotechnology Inc. is strategically located in British Columbia, Canada, known to be a cannabis friendly province. The British Columbia cannabis industry produces 40 percent of all Canadian cannabis, making cannabis among the most valuable cash crops in the province. While CIIX has been laying the groundwork to enter the legal cannabis market for some time, the complete legalization of cannabis in Canada provides another great opportunity for CIIX to enter the market."
"The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health," concludes Wang.
About ChineseInvestors.com (OTCQB: CIIX)
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail, online and direct sales of hemp-based products and other health related products.
For more information, visit ChineseInvestors.com
Subscribe and watch our video commentaries: https://www.youtube.com/user/Chinesefncom
Follow us on Twitter for real-time Company updates: https://twitter.com/ChineseFNEnglsh
Like us on Facebook to receive live feeds: https://www.facebook.com/Chinesefncom
Add us on WeChat: Chinesefn or download iPhone iOS App: Chinesefn
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Contact: ChineseInvestors.com, Inc. 227 W. Valley Blvd, #208 A San Gabriel, CA 91776 Investor Relations: Alan Klitenic +1-214-636-2548 Corporate Communications: NetworkNewsWire (NNW) New York, New York http://www.NetworkNewsWire.com +1-212-418-1217 Office Editor@NetworkNewsWire.com
SOURCE ChineseInvestors.com, Inc.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All